problems with conversion of INactive Thyroid Hormone T4 to active thyroid hormone t3 can cause symptoms and signs of hypothyroidism
Thyroid hormones play a crucial role in regulating your body's metabolism and is essential for brain development in infants. The thyroid hormones exist in two main forms: thyroxine, also known as T4, and triiodothyronine, or T3. T4, with its 4 iodine atoms, transforms into T3 when one iodine atom is removed, resulting in a potent hormone that drives cellular functions. This conversion mainly occurs in the liver and the gut.
T3 emerges as the dominant thyroid hormone, boasting 7-10 times more potency than its T4 counterpart. As T4 acts as the precursor thyroid hormone, paving the way for T3 to become the active thyroid hormone, a fascinating process unfolds when an "opposite mirror-image" iodine is detached from T4, giving rise to reverse T3, also known as RT3.
Reverse T3, or RT3, plays a fascinating role in the thyroid system by acting as a natural brake for the body's functions. While T3 typically fuels our bodily processes, there are instances, such as during critical illness, where it's beneficial for the body to curb its activities. Factors like stress, extreme dieting, low serum iron levels, cortisol deficiencies, and diabetes can trigger an uptick in RT3 production. This intricate mechanism showcases how the thyroid system delicately balances acceleration and deceleration to support overall health and well-being.
If individuals exhibit normal T4 levels alongside low or diminished T3 levels, it raises concerns about a potential thyroid hormone conversion issue. The thyroid gland primarily secretes thyroxine, also known as T4, with a smaller amount of triiodothyronine, or T3, being produced as well. The conversion of T4 to T3 accounts for the majority of T3 production. However, various factors can impact this conversion process, which will be explored further in this post.
Before delving into the factors influencing the conversion of T4 to T3, let's briefly touch on the process itself. The enzyme 5′-deiodinase plays a crucial role in this conversion, with three forms - deiodinase type I, deiodinase type II, and deiodinase type III. While type I and type II deiodinases are primarily responsible for converting T4 to T3, type III deiodinase is more involved in the inactivation of T4 and T3. The majority of this conversion occurs in the liver, although some also takes place in the gastrointestinal tract. Therefore, individuals with liver issues or gut dysbiosis may experience challenges in the conversion of T4 to T3, potentially impacting their thyroid hormone levels. Additionally, a portion of T4 is converted into reverse T3.
Why should I care how much T4 is converted to T3?
The importance of converting T4 into T3 lies in the fact that T3 is the active form of thyroid hormone. Unfortunately, not all endocrinologists conduct tests for T3, but when they do, they typically assess total T3, where most T3 is protein-bound, or free T3, which is unbound to a protein and directly interacts with the thyroid receptor. A scenario where an individual has normal T4 levels but low T3 levels indicates a hypothyroid condition. While many medical doctors focus on testing TSH and T4 levels, it's essential to also evaluate free T3 and free T4 to obtain a comprehensive view of thyroid function. Including reverse T3 and thyroid antibodies in the initial thyroid panel can offer valuable insights into thyroid health.
What is the rationale behind the prevalent practice among medical professionals of prescribing synthetic T4?
In cases of hypothyroidism, the typical approach by medical professionals is to prescribe levothyroxine, a synthetic form of T4, with Synthroid being a popular choice among others. While T3 is the active hormone that binds to receptors, the question arises: should T3 be the go-to treatment instead? Some practitioners may suggest synthetic T3 like Cytomel, but caution is warranted due to the risk of inducing hyperthyroidism with high dosages. Synthetic T4 can convert to T3, yet this conversion may be hindered in individuals with specific issues. Opting for a natural thyroid hormone blend like Armour or Nature-Throid, containing T4, T3, T1, T2, and calcitonin, may offer a more balanced approach for those without conversion concerns.
Factors that impede the conversion of T4 to T3:
Now that we have a deeper understanding of the importance of T3 in thyroid function, let's explore the six key factors that can hinder the conversion of T4 to T3. Understanding these factors is crucial in addressing any potential issues and optimizing thyroid health.
By understanding and addressing these factors, individuals can take proactive steps to optimize thyroid health and overall well-being. Remember, a holistic approach that considers various aspects of health is key to supporting optimal thyroid function.
Factor #1: CHALLENGES AFFECTING THE LIVER
This unexpected discovery challenges the conventional belief that liver health issues always impede the conversion of T4 to T3. In fact, the study on obese adolescents with non-alcoholic fatty liver suggests that the liver might adapt by increasing deiodinase activity to compensate for fat accumulation. This adaptive response sheds light on the intricate mechanisms at play in thyroid hormone conversion and emphasizes the need for a nuanced approach to supporting liver function in individuals with T4 to T3 conversion challenges.
While interventions like milk thistle and N-acetylcysteine can be beneficial in addressing T4 to T3 conversion issues, it's crucial to recognize the dynamic nature of the liver-thyroid relationship. By understanding the complexities involved, individuals can tailor their approach to liver support and optimize thyroid function effectively. This study underscores the importance of exploring the multifaceted interactions within the body to promote holistic health and well-being.
Factor # 2: IMBALANCE IN THE GUT FLORA (Dysbiosis)
Furthermore, the delicate balance of gut flora is essential for optimal thyroid function, as the beneficial bacteria are key players in the conversion process of T4 to T3. While current research may have limitations in fully elucidating the impact of gut dysbiosis on this conversion, it remains imperative to address any disruptions in gut microbiota balance. In fact, even if overt conversion issues are not immediately evident, restoring gut health is crucial for overall well-being.
Interestingly, a study has even suggested a potential link between Crohn's disease, an inflammatory bowel condition, and impaired conversion of T4 to T3. This highlights the intricate interplay between gut health and thyroid function, underscoring the importance of addressing any gut imbalances to support optimal thyroid hormone conversion. By nurturing a healthy gut environment, individuals can potentially enhance their thyroid health and overall vitality.
Factor # 3: infufficient Trace mineral Selenium
Selenium, a crucial trace mineral, is intricately involved in the functionality of the iodothyronine deiodinases, specifically in the form of selenocysteine. These enzymes play a pivotal role in the regulation of both circulating and intracellular levels of T3, a key thyroid hormone. Research has consistently shown the detrimental impact of selenium deficiency on the conversion of T4 to T3, highlighting the essential role this mineral plays in thyroid function.
However, the severity of this correlation becomes more pronounced in cases of severe selenium deficiency. Studies have demonstrated that a significant decrease in deiodinase activity occurs only when selenium levels drop by over 80%. This underscores the critical importance of maintaining adequate selenium levels for optimal thyroid hormone conversion and overall thyroid health.
In essence, selenium deficiency can disrupt the delicate balance of thyroid hormone conversion, emphasizing the need to address and rectify any insufficiencies to support optimal thyroid function. By ensuring adequate selenium intake through dietary sources or supplementation, individuals can potentially mitigate conversion issues and promote better thyroid health in the long run.
Factor # 4: Stress
Elevated cortisol levels can have a significant impact on the conversion of T4 to T3, as studies have shown that stress can inhibit both type I iodothyronine 5′-deiodinase activity and type II 5′-deiodinase activity. Cortisol, known as the stress hormone, can interfere with the normal functioning of these crucial enzymes involved in thyroid hormone conversion. Therefore, managing stress effectively is not only important for overall well-being but also plays a key role in maintaining optimal thyroid function.
Incorporating stress-reducing practices such as mindfulness meditation, yoga, deep breathing exercises, or engaging in activities that bring joy and relaxation can help lower cortisol levels and support the conversion of T4 to T3. By addressing stress and improving stress management skills, individuals can potentially enhance thyroid hormone conversion and promote better thyroid health overall. Remember, a holistic approach that considers both physical and emotional well-being is essential for optimal thyroid function.
Factor # 5: SPECIFIC DRUGS
Amiodarone, a potent anti-arrhythmic medication, poses a unique challenge in thyroid hormone conversion due to its structural resemblance to thyroid hormones. This similarity can lead to the inhibition of the crucial enzyme 5′-deiodinase, disrupting the conversion of T4 to T3 and potentially affecting thyroid function. On the other hand, beta blockers are commonly prescribed for hyperthyroid conditions, but it's important to note that specific ones like propranolol, alprenolol, atenolol, and metoprolol can also impact the conversion process. These medications may interfere with the enzymatic activity involved in thyroid hormone conversion, underscoring the need for careful consideration and monitoring when managing thyroid health in patients taking these drugs. By recognizing the influence of these medications on thyroid function, healthcare providers can tailor treatment plans to optimize thyroid hormone conversion and support overall thyroid health.
Factor # 6: Pro-inflammatory Immune Messengers
Our remarkable immune system produces a variety of cells and chemicals to facilitate communication among different cell types. These chemical messengers can either initiate inflammation or prompt cells to initiate a healing response. Specifically, the chemicals responsible for triggering inflammation are known as pro-inflammatory cytokines.
The presence of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) can have a significant impact on the activity of type 2 5′-deiodinase (5’D-I) enzymes. In conditions like Hashimoto’s Thyroiditis and Graves’ Disease, where autoimmune responses are heightened, these cytokines play a crucial role in inhibiting the conversion of T4 to T3. The dysregulation caused by these pro-inflammatory messengers further complicates the delicate balance of thyroid hormone conversion, highlighting the intricate relationship between inflammation and thyroid function. By recognizing the influence of these cytokines in autoimmune thyroid conditions, healthcare providers can tailor treatment strategies to address the underlying inflammatory processes and support optimal thyroid health.
In summary, when normal T4 levels are accompanied by low T3 levels, it often signals a potential conversion issue involving the pivotal enzyme 5′-deiodinase. Therefore, when evaluating thyroid function, it is crucial to not only assess TSH and free T4 levels but also include free T3 and reverse T3 in the panel for a comprehensive analysis. By incorporating these additional markers, healthcare providers can gain a more holistic understanding of the intricate dynamics within the thyroid system.
Furthermore, there are six key factors that can hinder the conversion of T4 to T3, shedding light on the delicate balance required for optimal thyroid function. These factors encompass challenges with liver health, disruptions in gut microbiota balance (known as gut dysbiosis), deficiencies in essential nutrients like selenium, the impact of elevated cortisol levels due to stress, potential interference from certain medications, and the influence of pro-inflammatory cytokines on the conversion process. Understanding and addressing these factors can play a crucial role in supporting thyroid health and overall well-being.
Always remember one of my mantras., "The more you know about how your body works, the better you can take care of yourself."
For more details about the natural approach I take with my patients, take a look at the book I wrote entitled: Reclaim Your Life; Your Guide To Revealing Your Body's Life-Changing Secrets For Renewed Health. It is available in my office or at Amazon and many other book outlets. If you found value in this article, please use the social sharing icons at the top of this post and please share with those you know who are still suffering with chronic health challenges, despite receiving medical management. Help me reach more people so they may regain their zest for living! Thank you!
ALL THE BEST – DR. KARL R.O.S. JOHNSON, DC – DIGGING DEEPER TO FIND SOLUTIONS
References:
1. Köhrle J. The deiodinase family: selenoenzymes regulating thyroid hormone availability and action. Cell Mol Life Sci. 2000 Dec;57(13-14):1853-63. doi: 10.1007/PL00000667. PMID: 11215512; PMCID: PMC11147027.
2. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab. 2003 Mar;88(3):1384-8. doi: 10.1210/jc.2002-021291. PMID: 12629133.
3. Bilgin H, Pirgon Ö. Thyroid function in obese children with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2014 Sep;6(3):152-7. doi: 10.4274/Jcrpe.1488. PMID: 25241608; PMCID: PMC4293643.
4. Vierhapper H, Grubeck-Loebenstein B, Ferenci P, Lochs H, Bratusch-Marrain P, Waldhäusl W. Alterations in thyroxine metabolism in Crohn's disease. Hepatogastroenterology. 1981 Feb;28(1):31-3. PMID: 6783498.
5. Bates JM, Spate VL, Morris JS, St Germain DL, Galton VA. Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development. Endocrinology. 2000 Jul;141(7):2490-500. doi: 10.1210/endo.141.7.7571. PMID: 10875250.
6. Arthur JR, Nicol F, Beckett GJ. Selenium deficiency, thyroid hormone metabolism, and thyroid hormone deiodinases. Am J Clin Nutr. 1993 Feb;57(2 Suppl):236S-239S. doi: 10.1093/ajcn/57.2.236S. PMID: 8427195.
7. Beckett GJ, Beddows SE, Morrice PC, Nicol F, Arthur JR. Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem J. 1987 Dec 1;248(2):443-7. doi: 10.1042/bj2480443. PMID: 3435458; PMCID: PMC1148561.
8. DePalo D, Kinlaw WB, Zhao C, Engelberg-Kulka H, St Germain DL. Effect of selenium deficiency on type I 5'-deiodinase. J Biol Chem. 1994 Jun 10;269(23):16223-8. PMID: 8206925.
9. Brtko J, Macejová D, Knopp J, Kvetnanský R. Stress is associated with inhibition of type I iodothyronine 5'-deiodinase activity in rat liver. Ann N Y Acad Sci. 2004 Jun;1018:219-23. doi: 10.1196/annals.1296.026. PMID: 15240372.
10. Hidal JT, Kaplan MM. Inhibition of thyroxine 5'-deiodination type II in cultured human placental cells by cortisol, insulin, 3', 5'-cyclic adenosine monophosphate, and butyrate. Metabolism. 1988 Jul;37(7):664-8. doi: 10.1016/0026-0495(88)90087-x. PMID: 2838733.
11. Song S, Oka T. Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium. Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1119-24. doi: 10.1152/ajpendo.00571.2002. Epub 2003 Feb 11. PMID: 12582014.
12. Ha HR, Stieger B, Grassi G, Altorfer HR, Follath F. Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):807-14. doi: 10.1007/s002280050701. PMID: 10805058.
13. Perrild H, Hansen JM, Skovsted L, Christensen LK. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin Endocrinol (Oxf). 1983 Feb;18(2):139-42. doi: 10.1111/j.1365-2265.1983.tb03196.x. PMID: 6133659.
14. Ogiwara T, Araki O, Morimura T, Tsunekawa K, Mori M, Murakami M. A novel mechanism for the inhibition of type 2 iodothyronine deiodinase by tumor necrosis factor α: involvement of proteasomal degradation. Endocr J. 2013;60(9):1035-45. doi: 10.1507/endocrj.ej11-0144. Epub 2013 May 30. PMID: 23719846.
15. Molnár I, Balázs C, Szegedi G, Sipka S. Inhibition of type 2,5'-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue. Immunol Lett. 2002 Jan 1;80(1):3-7. doi: 10.1016/s0165-2478(01)00301-7. PMID: 11716958.
16. Ongphiphadhanakul B, Fang SL, Tang KT, Patwardhan NA, Braverman LE. Tumor necrosis factor-alpha decreases thyrotropin-induced 5'-deiodinase activity in FRTL-5 thyroid cells. Eur J Endocrinol. 1994 May;130(5):502-7. doi: 10.1530/eje.0.1300502. PMID: 8180680.
